TCRX - Tscan Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TCRX is currently covered by 2 analysts with an average price target of $12.38. This is a potential upside of $6.64 (115.68%) from yesterday's end of day stock price of $5.74.

Tscan Therapeutics's activity chart (see below) currently has 1 price targets and 13 ratings on display. The stock rating distribution of TCRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 96 days.

Highest price target for TCRX is $15, Lowest price target is $10, average price target is $12.38.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 13-Aug-2024. First documented stock forecast 17-Dec-2021.

Best performing analysts who are covering TCRX - Tscan Therapeutics:

David Nierengarten Andrew Fein

Currently out of the existing stock ratings of TCRX, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$9.26 (161.32%)

$15

1 months 3 days ago

0/8 (0%)

$9.14 (155.97%)

Buy

$10

$4.26 (74.22%)

$10

1 months 3 days ago

2/4 (50%)

$4.14 (70.65%)

192

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TCRX (Tscan Therapeutics) average time for price targets to be met?

On average it took 96 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on TCRX (Tscan Therapeutics) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on TCRX (Tscan Therapeutics) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on TCRX (Tscan Therapeutics)?

David Nierengarten works at WEDBUSH and has 7 price targets and 5 ratings on TCRX

Which analyst is the currently most bullish on TCRX (Tscan Therapeutics)?

Andrew Fein with highest potential upside - $9.26

Which analyst is the currently most reserved on TCRX (Tscan Therapeutics)?

David Nierengarten with lowest potential downside - $4.26

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?